{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:33:41Z","timestamp":1795095221564,"version":"4.10.2"},"reference-count":177,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Rhodes Trust"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>After myocardial infarction (MI), patients with type 2 diabetes have an increased rate of adverse outcomes, compared to patients without. Diabetes confers a 1.5\u20132-fold increase in early mortality and, importantly, this discrepancy has been consistent over recent decades, despite advances in treatment and overall survival. Certain assumptions have emerged to explain this increased risk, such as differences in infarct size or coronary artery disease severity. Here, we re-evaluate that evidence and show how contemporary analyses using state-of-the-art characterization tools suggest that the received wisdom tells an incomplete story. Simultaneously, epidemiological and mechanistic biological data suggest additional factors relating to processes of diabetes-related inflammation might play a prominent role. Inflammatory processes after MI mediate injury and repair and are thus a potential therapeutic target. Recent studies have shown how diabetes affects immune cell numbers and drives changes in the bone marrow, leading to pro-inflammatory gene expression and functional suppression of healing and repair. Here, we review and re-evaluate the evidence around adverse prognosis in patients with diabetes after MI, with emphasis on how targeting processes of inflammation presents unexplored, yet valuable opportunities to improve cardiovascular outcomes in this vulnerable patient group.<\/jats:p>","DOI":"10.1093\/cvr\/cvae142","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T05:28:37Z","timestamp":1721107717000},"page":"1241-1252","source":"Crossref","is-referenced-by-count":27,"title":["Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes"],"prefix":"10.1093","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0043-7263","authenticated-orcid":false,"given":"Tafadzwa T J","family":"Kufazvinei","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford , Oxford OX3 9DU , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Chai","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford , Oxford OX3 9DU , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A","family":"Boden","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford , Oxford OX3 9DU , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith M","family":"Channon","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford , Oxford OX3 9DU , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8046-1688","authenticated-orcid":false,"given":"Robin P","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford , Oxford OX3 9DU , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"key":"2024092115060900000_cvae142-B1","doi-asserted-by":"crossref","first-page":"14790","DOI":"10.1038\/s41598-020-71908-9","article-title":"Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"2024092115060900000_cvae142-B2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"2024092115060900000_cvae142-B3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijcard.2016.04.182","article-title":"A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction","volume":"217","author":"Bauters","year":"2016","journal-title":"Int J Cardiol"},{"key":"2024092115060900000_cvae142-B4","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3390\/jcm9082555","article-title":"The effect of diabetes on prognosis following myocardial infarction treated with primary angioplasty and potent antiplatelet therapy","volume":"9","author":"Simek","year":"2020","journal-title":"J Clin Med"},{"key":"2024092115060900000_cvae142-B5","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1177\/2047487319901063","article-title":"Heart failure is a common complication after acute myocardial infarction in patients with diabetes: a nationwide study in the SWEDEHEART registry","volume":"27","author":"Ritsinger","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2024092115060900000_cvae142-B6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.amjmed.2018.03.004","article-title":"Diabetes mellitus and cardiogenic shock complicating acute myocardial infarction","volume":"131","author":"Echouffo-Tcheugui","year":"2018","journal-title":"Am J Med"},{"key":"2024092115060900000_cvae142-B7","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1016\/j.jacc.2020.10.033","article-title":"Incidence and predictors of out-of-hospital cardiac arrest within 90 days after myocardial infarction","volume":"76","author":"Fax\u00e9n","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjcard.2021.08.019","article-title":"Predictors of recurrent ischemic events in patients with ST-segment elevation myocardial infarction","volume":"159","author":"Galasso","year":"2021","journal-title":"Am J Cardiol"},{"key":"2024092115060900000_cvae142-B9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0735-1097(91)90792-8","article-title":"Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis","volume":"18","author":"de Vreede","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jacc.2016.05.049","article-title":"Predicting in-hospital mortality in patients with acute myocardial infarction","volume":"68","author":"McNamara","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B11","first-page":"153","volume-title":"Diabetes: from research to clinical practice: volume 4","author":"Milazzo","year":"2021"},{"key":"2024092115060900000_cvae142-B12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0002-9343(56)90191-7","article-title":"Survival of diabetic patients after myocardial infarction","volume":"20","author":"Bradley","year":"1956","journal-title":"Am J Med"},{"key":"2024092115060900000_cvae142-B13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2337\/diacare.8.3.230","article-title":"Prevalence and mortality of acute myocardial infarction in patients with diabetes","volume":"8","author":"Rytter","year":"1985","journal-title":"Diabetes Care"},{"key":"2024092115060900000_cvae142-B14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0735-1097(97)00118-6","article-title":"Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries","volume":"30","author":"Mak","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B15","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archinte.164.13.1457","article-title":"Implications of diabetes in patients with acute coronary syndromes: the global registry of acute coronary events","volume":"164","author":"Franklin","year":"2004","journal-title":"Arch Intern Med"},{"key":"2024092115060900000_cvae142-B16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/jcm12030917","article-title":"Survival of myocardial infarction patients with diabetes mellitus at the invasive era (results from the v\u00e1rosmajor myocardial infarction registry)","volume":"12","author":"Skoda","year":"2023","journal-title":"J Clin Med"},{"key":"2024092115060900000_cvae142-B17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCULATIONAHA.122.061983","article-title":"Coronary artery lesion lipid content and plaque burden in diabetic and nondiabetic patients: PROSPECT II","volume":"147","author":"Gyldenkerne","year":"2023","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B18","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.amjcard.2011.11.046","article-title":"Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI)","volume":"109","author":"Brener","year":"2012","journal-title":"Am J Cardiol"},{"key":"2024092115060900000_cvae142-B19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2337\/dc22-0042","article-title":"Case fatality of patients with type 1 diabetes after myocardial infarction","volume":"45","author":"Kerola","year":"2022","journal-title":"Diabetes Care"},{"key":"2024092115060900000_cvae142-B20","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.1975.03260070065026","article-title":"Hyperglycemia during acute myocardial infarction: a six-year follow-up study","volume":"233","author":"Ravid","year":"1975","journal-title":"JAMA"},{"key":"2024092115060900000_cvae142-B21","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/S0735-1097(02)02483-X","article-title":"Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?","volume":"40","author":"Wahab","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ehjcvp\/pvv023","article-title":"Meta-analysis of admission hyperglycaemia in acute myocardial infarction patients treated with primary angioplasty: a cause or a marker of mortality?","volume":"1","author":"Singh","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2024092115060900000_cvae142-B23","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/CIRCULATIONAHA.107.188629","article-title":"Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism","volume":"117","author":"Deedwania","year":"2008","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B24","doi-asserted-by":"crossref","first-page":"110644","DOI":"10.1016\/j.diabres.2023.110644","article-title":"Glycaemic control in people with diabetes following acute myocardial infarction","volume":"199","author":"Esdaile","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"2024092115060900000_cvae142-B25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12933-022-01655-w","article-title":"Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction","volume":"21","author":"Baviera","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2024092115060900000_cvae142-B26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12933-019-0970-6","article-title":"Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis","volume":"18","author":"Pan","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"2024092115060900000_cvae142-B27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/2048872618803701","article-title":"Editor's choice-impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction","volume":"8","author":"Rossello","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2024092115060900000_cvae142-B28","doi-asserted-by":"crossref","DOI":"10.1177\/1479164120973676","article-title":"Diabetes, metformin and glucose lowering therapies after myocardial infarction: insights from the SWEDEHEART registry","volume":"17","author":"Ritsinger","year":"2020","journal-title":"Diab Vasc Dis Res"},{"key":"2024092115060900000_cvae142-B29","doi-asserted-by":"crossref","first-page":"e0183664","DOI":"10.1371\/journal.pone.0183664","article-title":"A systematic review and meta-analysis of the protective effects of metformin in experimental myocardial infarction","volume":"12","author":"Hesen","year":"2017","journal-title":"PLoS One"},{"key":"2024092115060900000_cvae142-B30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10557-013-6504-7","article-title":"Chronic metformin treatment is associated with reduced myocardial infarct size in diabetic patients with ST-segment elevation myocardial infarction","volume":"28","author":"Lexis","year":"2014","journal-title":"Cardiovasc Drugs Ther"},{"key":"2024092115060900000_cvae142-B31","doi-asserted-by":"crossref","first-page":"e002314","DOI":"10.1161\/JAHA.115.002314","article-title":"Metformin and myocardial injury in patients with diabetes and ST-segment elevation myocardial infarction: a propensity score matched analysis","volume":"4","author":"Basnet","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2024092115060900000_cvae142-B32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0735-1097(98)00557-9","article-title":"Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction","volume":"33","author":"Garratt","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1012979622945","article-title":"Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction","volume":"12","author":"Halkin","year":"2001","journal-title":"J Thromb Thrombolysis"},{"key":"2024092115060900000_cvae142-B34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1053\/euhj.1999.1999","article-title":"Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)","volume":"21","author":"Klamann","year":"2000","journal-title":"Eur Heart J"},{"key":"2024092115060900000_cvae142-B35","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1210\/jc.2010-0449","article-title":"Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction","volume":"95","author":"Zeller","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2024092115060900000_cvae142-B36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/dmrr.498","article-title":"Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry","volume":"21","author":"Danchin","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"key":"2024092115060900000_cvae142-B37","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2024092115060900000_cvae142-B38","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"2024092115060900000_cvae142-B39","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"2024092115060900000_cvae142-B40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"2024092115060900000_cvae142-B41","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa2004967","article-title":"Cardiovascular outcomes with ertugliflozin in type 2 diabetes","volume":"383","author":"Cannon","year":"2020","journal-title":"N Engl J Med"},{"key":"2024092115060900000_cvae142-B42","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2024092115060900000_cvae142-B43","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"2024092115060900000_cvae142-B44","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","article-title":"SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control","volume":"17","author":"Cowie","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2024092115060900000_cvae142-B45","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"2024092115060900000_cvae142-B46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12933-023-01814-7","article-title":"SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis","volume":"22","author":"Sardu","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"2024092115060900000_cvae142-B47","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.jacc.2022.03.353","article-title":"Sodium glucose cotransporter-2 inhibition for acute myocardial infarction","volume":"79","author":"Udell","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12916-023-02781-2","article-title":"SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes","volume":"21","author":"Marfella","year":"2023","journal-title":"BMC Med"},{"key":"2024092115060900000_cvae142-B49","doi-asserted-by":"crossref","first-page":"1012220","DOI":"10.3389\/fcvm.2022.1012220","article-title":"In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: insights from the SGLT2-I AMI PROTECT study","volume":"9","author":"Cesaro","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2024092115060900000_cvae142-B50","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1093\/eurheartj\/ehac494","article-title":"Empagliflozin in acute myocardial infarction: the EMMY trial","volume":"43","author":"von Lewinski","year":"2022","journal-title":"Eur Heart J."},{"key":"2024092115060900000_cvae142-B51","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12933-023-01904-6","article-title":"Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction\u2014a post-hoc analysis of the EMMY trial","volume":"22","author":"Benedikt","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"2024092115060900000_cvae142-B52","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300286","article-title":"Dapagliflozin in myocardial infarction without diabetes or heart failure","volume":"3","author":"James","year":"2024","journal-title":"NEJM Evid"},{"key":"2024092115060900000_cvae142-B53","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa2314051","article-title":"Empagliflozin after acute myocardial infarction","volume":"390","author":"Butler","year":"2024","journal-title":"N Engl J Med"},{"key":"2024092115060900000_cvae142-B54","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0735-1097(99)00250-8","article-title":"Cause of death in clinical research: time for a reassessment?","volume":"34","author":"Lauer","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1532-429X-12-61","article-title":"Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance","volume":"12","author":"Mather","year":"2010","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024092115060900000_cvae142-B56","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ahj.2007.06.020","article-title":"Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy","volume":"154","author":"Alegria","year":"2007","journal-title":"Am Heart J"},{"key":"2024092115060900000_cvae142-B57","doi-asserted-by":"crossref","first-page":"e015736","DOI":"10.1136\/bmjopen-2016-015736","article-title":"'Just like a normal pain', what do people with diabetes mellitus experience when having a myocardial infarction: a qualitative study recruited from UK hospitals","volume":"7","author":"Berman","year":"2017","journal-title":"BMJ Open"},{"key":"2024092115060900000_cvae142-B58","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","article-title":"Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials","volume":"67","author":"Stone","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B59","doi-asserted-by":"crossref","first-page":"e003951","DOI":"10.1161\/CIRCIMAGING.116.003951","article-title":"Recent advances in cardiovascular magnetic resonance: techniques and applications","volume":"10","author":"Salerno","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2024092115060900000_cvae142-B60","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/CIRCIMAGING.112.974998","article-title":"Prognostic impact of hyperglycemia in nondiabetic and diabetic patients with ST-elevation myocardial infarction: insights from contrast-enhanced magnetic resonance imaging","volume":"5","author":"Eitel","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"2024092115060900000_cvae142-B61","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/dom.13002","article-title":"Relationship between diabetes and ischaemic injury among patients with revascularized ST-elevation myocardial infarction","volume":"19","author":"Reinstadler","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"2024092115060900000_cvae142-B62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ahj.2016.05.003","article-title":"The association of left ventricular ejection fraction with clinical outcomes after myocardial infarction: findings from the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry\u2013Get with the Guidelines (GWTG) Medicare-linked database","volume":"178","author":"Sutton","year":"2016","journal-title":"Am Heart J"},{"key":"2024092115060900000_cvae142-B63","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0735-1097(02)02065-X","article-title":"Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study","volume":"40","author":"Goraya","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B64","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/eurheartj\/ehs393","article-title":"Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox","volume":"34","author":"Niccoli","year":"2013","journal-title":"Eur Heart J"},{"issue":"Suppl.","key":"2024092115060900000_cvae142-B65","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jcmg.2012.01.008","article-title":"Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes","volume":"5","author":"Marso","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024092115060900000_cvae142-B66","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10554-009-9483-9","article-title":"Comparison of atherosclerotic plaque burden and composition between diabetic and non diabetic patients by non invasive CT angiography","volume":"25","author":"Ibebuogu","year":"2009","journal-title":"Int J Cardiovasc Imaging"},{"key":"2024092115060900000_cvae142-B67","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/hrt.2003.021014","article-title":"Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention","volume":"90","author":"Morgan","year":"2004","journal-title":"Heart"},{"key":"2024092115060900000_cvae142-B68","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(21)00249-X","article-title":"Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study","volume":"397","author":"Erlinge","year":"2021","journal-title":"Lancet"},{"key":"2024092115060900000_cvae142-B69","doi-asserted-by":"crossref","first-page":"e009245","DOI":"10.1161\/JAHA.118.009245","article-title":"Coronary plaque characteristics in patients with diabetes mellitus who presented with acute coronary syndromes","volume":"7","author":"Sugiyama","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2024092115060900000_cvae142-B70","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.4244\/EIJ-D-21-00089","article-title":"Intracoronary optical coherence tomography: state of the art and future directions","volume":"17","author":"Ali","year":"2021","journal-title":"EuroIntervention"},{"key":"2024092115060900000_cvae142-B71","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0735-1097(96)00397-X","article-title":"Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience","volume":"28","author":"Woodfield","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B72","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/cvr\/cvaa003","article-title":"ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on \u2018coronary microvascular dysfunction in cardiovascular disease\u2019","volume":"116","author":"Padro","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2024092115060900000_cvae142-B73","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehab775","article-title":"Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis","volume":"43","author":"Kelshiker","year":"2022","journal-title":"Eur Heart J"},{"key":"2024092115060900000_cvae142-B74","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/ehjci\/jead023","article-title":"Incremental prognostic value of positron emission tomography-derived myocardial flow reserve in patients with and without diabetes mellitus","volume":"24","author":"Aljizeeri","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2024092115060900000_cvae142-B75","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12968-020-00667-3","article-title":"Incremental prognostic value of coronary flow reserve determined by phase-contrast cine cardiovascular magnetic resonance of the coronary sinus in patients with diabetes mellitus","volume":"22","author":"Kato","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024092115060900000_cvae142-B76","doi-asserted-by":"crossref","first-page":"765071","DOI":"10.3389\/fcvm.2021.765071","article-title":"Microvascular dysfunction in patients with type II diabetes mellitus: invasive assessment of absolute coronary blood flow and microvascular resistance reserve","volume":"8","author":"Gallinoro","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2024092115060900000_cvae142-B77","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijcard.2019.10.040","article-title":"Prognostic impact of diabetes mellitus and index of microcirculatory resistance in patients undergoing fractional flow reserve-guided revascularization","volume":"307","author":"Hu","year":"2020","journal-title":"Int J Cardiol"},{"key":"2024092115060900000_cvae142-B78","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12933-019-0833-1","article-title":"Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease","volume":"18","author":"Sara","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"2024092115060900000_cvae142-B79","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12933-022-01653-y","article-title":"Prognostic value of coronary microvascular dysfunction assessed by coronary angiography-derived index of microcirculatory resistance in diabetic patients with chronic coronary syndrome","volume":"21","author":"Zhang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2024092115060900000_cvae142-B80","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.echo.2014.02.010","article-title":"Prognostic meaning of coronary microvascular disease in type 2 diabetes mellitus: a transthoracic Doppler echocardiographic study","volume":"27","author":"Cortigiani","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"2024092115060900000_cvae142-B81","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"key":"2024092115060900000_cvae142-B82","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/2048872617727722","article-title":"Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: a subanalysis of the ATLANTIC trial","volume":"8","author":"Fabris","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2024092115060900000_cvae142-B83","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.amjcard.2005.01.088","article-title":"Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus","volume":"95","author":"Timmer","year":"2005","journal-title":"Am J Cardiol"},{"key":"2024092115060900000_cvae142-B84","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCULATIONAHA.110.985911","article-title":"Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment\u2013elevation myocardial infarction treated with percutaneous coronary intervention","volume":"124","author":"Timmer","year":"2011","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B85","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.59.1.8","article-title":"Diabetes and cardiovascular risk factors: the Framingham study","volume":"59","author":"Kannel","year":"1979","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B86","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.2337\/dc10-0286","article-title":"Diabetes, glycemic control, and new-onset heart failure in patients with stable coronary artery disease: data from the heart and soul study","volume":"33","author":"van Melle","year":"2010","journal-title":"Diabetes Care"},{"key":"2024092115060900000_cvae142-B87","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"2024092115060900000_cvae142-B88","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jchf.2014.10.007","article-title":"Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART registry (Swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies): a study of 199,851 patients admitted with index acute myocardial infarctions, 1996 to 2008","volume":"3","author":"Desta","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2024092115060900000_cvae142-B89","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ Res"},{"key":"2024092115060900000_cvae142-B90","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/CIRCULATIONAHA.107.727826","article-title":"Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction","volume":"118","author":"Kwong","year":"2008","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B91","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"2024092115060900000_cvae142-B92","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","article-title":"Impact of diabetes on cardiac structure and function","volume":"101","author":"Devereux","year":"2000","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B93","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12872-019-1084-5","article-title":"Dysglycemia and increased left ventricle mass in normotensive patients admitted with a first myocardial infarction: prognostic implications of dysglycemia during 14 years of follow-up","volume":"19","author":"Pararajasingam","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"2024092115060900000_cvae142-B94","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jacc.2023.03.383","article-title":"Sex difference in outcomes of acute myocardial infarction in young patients","volume":"81","author":"Sawano","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B95","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jama.1996.03530340041027","article-title":"Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators","volume":"275","author":"Weaver","year":"1996","journal-title":"JAMA"},{"key":"2024092115060900000_cvae142-B96","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/clc.23662","article-title":"Gender differences in acute myocardial infarction\u2014a nationwide German real-life analysis from 2014 to 2017","volume":"44","author":"Kuehnemund","year":"2021","journal-title":"Clin Cardiol"},{"key":"2024092115060900000_cvae142-B97","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCULATIONAHA.106.664979","article-title":"Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction","volume":"115","author":"Milcent","year":"2007","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B98","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.108.789800","article-title":"Sex differences in medical care and early death after acute myocardial infarction","volume":"118","author":"Jneid","year":"2008","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B99","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/hrt.2006.106781","article-title":"Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20 290 patients from the AMIS Plus Registry","volume":"93","author":"Radovanovic","year":"2007","journal-title":"Heart"},{"key":"2024092115060900000_cvae142-B100","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jcin.2021.12.033","article-title":"Sex differences in management and outcomes of acute myocardial infarction patients presenting with cardiogenic shock","volume":"15","author":"Elgendy","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2024092115060900000_cvae142-B101","doi-asserted-by":"crossref","first-page":"109117","DOI":"10.1016\/j.diabres.2021.109117","article-title":"Heterogenicity of diabetes as a risk factor for all-cause mortality after acute myocardial infarction: age and sex impact","volume":"182","author":"Plakht","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"2024092115060900000_cvae142-B102","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/CIRCULATIONAHA.114.009480","article-title":"Sex differences in long-term mortality after myocardial infarction: a systematic review","volume":"130","author":"Bucholz","year":"2014","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2016.11.010","article-title":"Sex differences in acute myocardial infarction: is it only the age?","volume":"231","author":"Valero-Masa","year":"2017","journal-title":"Int J Cardiol"},{"key":"2024092115060900000_cvae142-B104","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.amjcard.2016.12.035","article-title":"Impact of diabetes mellitus on ischemic events in men and women after percutaneous coronary intervention","volume":"119","author":"Farhan","year":"2017","journal-title":"Am J Cardiol"},{"key":"2024092115060900000_cvae142-B105","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1136\/hrt.2007.135038","article-title":"Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA)","volume":"94","author":"Norhammar","year":"2008","journal-title":"Heart"},{"key":"2024092115060900000_cvae142-B106","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijcard.2020.08.002","article-title":"Acute myocardial infarction in the young with diabetes mellitus- national inpatient sample study with sex-based difference in outcomes","volume":"326","author":"Chakraborty","year":"2021","journal-title":"Int J Cardiol"},{"key":"2024092115060900000_cvae142-B107","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/cvr\/cvn335","article-title":"Oxidative stress and left ventricular remodelling after myocardial infarction","volume":"81","author":"Hori","year":"2009","journal-title":"Cardiovasc Res"},{"key":"2024092115060900000_cvae142-B108","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/eji.200940168","article-title":"Signaling by ROS drives inflammasome activation","volume":"40","author":"Martinon","year":"2010","journal-title":"Eur J Immunol"},{"key":"2024092115060900000_cvae142-B109","doi-asserted-by":"crossref","first-page":"C1640","DOI":"10.1152\/ajpcell.1998.275.6.C1640","article-title":"Activation of the JAK-STAT pathway by reactive oxygen species","volume":"275","author":"Simon","year":"1998","journal-title":"Am J Physiol"},{"key":"2024092115060900000_cvae142-B110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-\u03baB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res"},{"key":"2024092115060900000_cvae142-B111","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/01.CIR.0000012748.58444.08","article-title":"Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase","volume":"105","author":"Guzik","year":"2002","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B112","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.jacc.2009.07.031","article-title":"Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart","volume":"54","author":"Anderson","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B113","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/cvr\/cvaa287","article-title":"Angiogenesis after acute myocardial infarction","volume":"117","author":"Wu","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2024092115060900000_cvae142-B114","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.jacc.2005.08.045","article-title":"Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse","volume":"46","author":"Kido","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B115","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.2337\/diabetes.53.12.3226","article-title":"Hyperglycemia regulates hypoxia-inducible factor-1\u03b1 protein stability and function","volume":"53","author":"Catrina","year":"2004","journal-title":"Diabetes"},{"key":"2024092115060900000_cvae142-B116","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2337\/diabetes.53.9.2383","article-title":"Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes","volume":"53","author":"Marfella","year":"2004","journal-title":"Diabetes"},{"key":"2024092115060900000_cvae142-B117","doi-asserted-by":"crossref","first-page":"21655","DOI":"10.1038\/s41598-020-78676-6","article-title":"FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease","volume":"10","author":"Januszewski","year":"2020","journal-title":"Sci Rep"},{"key":"2024092115060900000_cvae142-B118","doi-asserted-by":"crossref","first-page":"e50739","DOI":"10.1371\/journal.pone.0050739","article-title":"Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization","volume":"7","author":"Ling","year":"2012","journal-title":"PLoS One"},{"key":"2024092115060900000_cvae142-B119","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41419-023-05935-5","article-title":"Vascular nitric oxide resistance in type 2 diabetes","volume":"14","author":"Bahadoran","year":"2023","journal-title":"Cell Death Dis"},{"key":"2024092115060900000_cvae142-B120","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1210\/jc.2019-00980","article-title":"Angiogenic abnormalities in diabetes mellitus: mechanistic and clinical aspects","volume":"104","author":"Fadini","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2024092115060900000_cvae142-B121","first-page":"918267","article-title":"Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing","volume":"2012","author":"Kolluru","year":"2012","journal-title":"Int J Vasc Med"},{"key":"2024092115060900000_cvae142-B122","doi-asserted-by":"crossref","first-page":"H1489","DOI":"10.1152\/ajpheart.00278.2006","article-title":"Role of changes in cardiac metabolism in development of diabetic cardiomyopathy","volume":"291","author":"An","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024092115060900000_cvae142-B123","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/01.CIR.100.19.1958","article-title":"Independent prognostic value of elevated C-reactive protein in unstable angina","volume":"100","author":"Ferreir\u00f3s","year":"1999","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B124","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0735-1097(99)00348-4","article-title":"Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty","volume":"34","author":"Buffon","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B125","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/HYPERTENSIONAHA.109.143131","article-title":"Peak C-reactive protein level predicts long-term outcomes in type B acute aortic dissection","volume":"55","author":"Sakakura","year":"2010","journal-title":"Hypertension"},{"key":"2024092115060900000_cvae142-B126","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjmed.2007.10.033","article-title":"C-reactive protein is an independent predictor of severity in community-acquired pneumonia","volume":"121","author":"Chalmers","year":"2008","journal-title":"Am J Med"},{"key":"2024092115060900000_cvae142-B127","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","article-title":"Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B128","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1161\/01.CIR.100.15.e65","article-title":"C-reactive protein, serum amyloid A protein, and coronary events","volume":"100","author":"Choudhury","year":"1999","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B129","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"2024092115060900000_cvae142-B130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrcardio.2016.185","article-title":"Inflammatory processes in cardiovascular disease: a route to targeted therapies","volume":"14","author":"Ruparelia","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2024092115060900000_cvae142-B131","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2024092115060900000_cvae142-B132","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/bph.14155","article-title":"Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges","volume":"175","author":"Huang","year":"2018","journal-title":"Br J Pharmacol"},{"key":"2024092115060900000_cvae142-B133","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1161\/CIRCULATIONAHA.108.769331","article-title":"High-mobility group box-1 in ischemia-reperfusion injury of the heart","volume":"117","author":"Andrassy","year":"2008","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B134","doi-asserted-by":"crossref","first-page":"H2805","DOI":"10.1152\/ajpheart.00299.2008","article-title":"Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion","volume":"294","author":"Zou","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024092115060900000_cvae142-B135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00395-012-0250-z","article-title":"S100a8\/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-\u03baB signaling","volume":"107","author":"Volz","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"2024092115060900000_cvae142-B136","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2007.08.004","article-title":"Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness","volume":"197","author":"Schoneveld","year":"2008","journal-title":"Atherosclerosis"},{"key":"2024092115060900000_cvae142-B137","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ Res"},{"key":"2024092115060900000_cvae142-B138","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2024092115060900000_cvae142-B139","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.4049\/jimmunol.180.10.6954","article-title":"Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice","volume":"180","author":"Riad","year":"2008","journal-title":"J Immunol"},{"key":"2024092115060900000_cvae142-B140","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1111\/jcmm.13201","article-title":"Mir-181a and miR-150 regulate dendritic cell immune inflammatory responses and cardiomyocyte apoptosis via targeting JAK 1\u2013STAT 1\/c-Fos pathway","volume":"21","author":"Zhu","year":"2017","journal-title":"J Cell Mol Med"},{"key":"2024092115060900000_cvae142-B141","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cophys.2017.09.001","article-title":"Cell biological mechanisms in regulation of the post-infarction inflammatory response","volume":"1","author":"Frangogiannis","year":"2018","journal-title":"Curr Opin Physiol"},{"key":"2024092115060900000_cvae142-B142","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3390\/cells10071676","article-title":"Role of neutrophils in cardiac injury and repair following myocardial infarction","volume":"10","author":"Ma","year":"2021","journal-title":"Cells"},{"key":"2024092115060900000_cvae142-B143","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/eurheartj\/eht331","article-title":"Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir","volume":"35","author":"van der Laan","year":"2013","journal-title":"Eur Heart J"},{"key":"2024092115060900000_cvae142-B144","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/cvr\/cvac012","article-title":"Rapid neutrophil mobilization by VCAM-1+ endothelial cell-derived extracellular vesicles","volume":"119","author":"Akbar","year":"2023","journal-title":"Cardiovasc Res"},{"key":"2024092115060900000_cvae142-B145","doi-asserted-by":"crossref","first-page":"e93344","DOI":"10.1172\/jci.insight.93344","article-title":"Endothelium-derived extracellular vesicles promote splenic monocyte mobilization in myocardial infarction","volume":"2","author":"Akbar","year":"2017","journal-title":"JCI Insight"},{"key":"2024092115060900000_cvae142-B146","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/eurheartj\/ehv195","article-title":"Acute myocardial infarction activates distinct inflammation and proliferation pathways in circulating monocytes, prior to recruitment, and identified through conserved transcriptional responses in mice and humans","volume":"36","author":"Ruparelia","year":"2015","journal-title":"Eur Heart J"},{"key":"2024092115060900000_cvae142-B147","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00011-013-0605-4","article-title":"Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus","volume":"62","author":"Ruparelia","year":"2013","journal-title":"Inflamm Res"},{"key":"2024092115060900000_cvae142-B148","first-page":"187","article-title":"Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype","volume":"38","author":"Horckmans","year":"2017","journal-title":"Eur Heart J"},{"key":"2024092115060900000_cvae142-B149","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.109.916346","article-title":"Monocytes: protagonists of infarct inflammation and repair after myocardial infarction","volume":"121","author":"Nahrendorf","year":"2010","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B150","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.0000155614.35441.69","article-title":"Tumor necrosis factor-\u03b1 receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study","volume":"111","author":"Valgimigli","year":"2005","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B151","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0002-8703(93)90526-F","article-title":"Elevated plasma interleukin-6 levels in patients with acute myocardial infarction","volume":"126","author":"Miyao","year":"1993","journal-title":"Am Heart J"},{"key":"2024092115060900000_cvae142-B152","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature11260","article-title":"Myocardial infarction accelerates atherosclerosis","volume":"487","author":"Dutta","year":"2012","journal-title":"Nature"},{"key":"2024092115060900000_cvae142-B153","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/CIRCRESAHA.110.227454","article-title":"Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction","volume":"107","author":"Leuschner","year":"2010","journal-title":"Circ Res"},{"key":"2024092115060900000_cvae142-B154","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1175202","article-title":"Identification of splenic reservoir monocytes and their deployment to inflammatory sites","volume":"325","author":"Swirski","year":"2009","journal-title":"Science"},{"key":"2024092115060900000_cvae142-B155","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt.1989","article-title":"Therapeutic siRNA silencing in inflammatory monocytes in mice","volume":"29","author":"Leuschner","year":"2011","journal-title":"Nat Biotechnol"},{"key":"2024092115060900000_cvae142-B156","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.phrs.2008.06.007","article-title":"The immune system and cardiac repair","volume":"58","author":"Frangogiannis","year":"2008","journal-title":"Pharmacol Res"},{"key":"2024092115060900000_cvae142-B157","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9149(87)90817-4","article-title":"Relation between use of anti-inflammatory agents and left ventricular free wall rupture during acute myocardial infarction","volume":"59","author":"Silverman","year":"1987","journal-title":"Am J Cardiol"},{"key":"2024092115060900000_cvae142-B158","first-page":"I204","article-title":"Deleterious effects of methylprednisolone in patients with myocardial infarction","volume":"53","author":"Roberts","year":"1976","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B159","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2024092115060900000_cvae142-B160","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B161","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"2024092115060900000_cvae142-B162","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cmet.2013.04.001","article-title":"Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis","volume":"17","author":"Nagareddy","year":"2013","journal-title":"Cell Metab"},{"key":"2024092115060900000_cvae142-B163","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.120.316653","article-title":"Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesis","volume":"127","author":"Flynn","year":"2020","journal-title":"Circ Res"},{"key":"2024092115060900000_cvae142-B164","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/CIRCRESAHA.120.317797","article-title":"Transient intermittent hyperglycemia-enhanced myelopoiesis and atherosclerosis","volume":"127","author":"Choudhury","year":"2020","journal-title":"Circ Res"},{"key":"2024092115060900000_cvae142-B165","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.120.046464","article-title":"Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis","volume":"144","author":"Edgar","year":"2021","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B166","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/ATVBAHA.118.310703","article-title":"Ly6CHi blood monocyte\/macrophage drive chronic inflammation and impair wound healing in diabetes mellitus","volume":"38","author":"Kimball","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024092115060900000_cvae142-B167","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.ahj.2007.06.038","article-title":"Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging","volume":"154","author":"Ripa","year":"2007","journal-title":"Am Heart J"},{"key":"2024092115060900000_cvae142-B168","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41591-018-0059-x","article-title":"The human heart contains distinct macrophage subsets with divergent origins and functions","volume":"24","author":"Bajpai","year":"2018","journal-title":"Nat Med"},{"key":"2024092115060900000_cvae142-B169","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ehf2.13144","article-title":"Heart failure after myocardial infarction: incidence and predictors","volume":"8","author":"Jen\u010da","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2024092115060900000_cvae142-B170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcmg.2022.09.015","article-title":"Acute response in the noninfarcted myocardium predicts long-term major adverse cardiac events after STEMI","volume":"16","author":"Shanmuganathan","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024092115060900000_cvae142-B171","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s44161-022-00094-w","article-title":"Neutrophils incite and macrophages avert electrical storm after myocardial infarction","volume":"1","author":"Grune","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"2024092115060900000_cvae142-B172","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","article-title":"Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans","volume":"106","author":"Esposito","year":"2002","journal-title":"Circulation"},{"key":"2024092115060900000_cvae142-B173","doi-asserted-by":"crossref","first-page":"42077","DOI":"10.1074\/jbc.M107101200","article-title":"Hyperglycemia-induced production of acute phase reactants in adipose tissue","volume":"276","author":"Lin","year":"2001","journal-title":"J Biol Chem"},{"key":"2024092115060900000_cvae142-B174","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res"},{"key":"2024092115060900000_cvae142-B175","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2016.07.768","article-title":"Arterial effects of canakinumab in patients with atherosclerosis and type 2 diabetes or glucose intolerance","volume":"68","author":"Choudhury","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B176","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.jacc.2018.03.002","article-title":"Anti-Inflammatory therapy with canakinumab for the prevention and management of diabetes","volume":"71","author":"Everett","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2024092115060900000_cvae142-B177","doi-asserted-by":"crossref","first-page":"e23231","DOI":"10.1096\/fj.202301078R","article-title":"Trained immunity in diabetes and hyperlipidemia: emerging opportunities to target cardiovascular complications and design new therapies","volume":"37","author":"Robinson","year":"2023","journal-title":"FASEB J"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvae142\/58594702\/cvae142.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/120\/11\/1241\/59220446\/cvae142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/120\/11\/1241\/59220446\/cvae142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T15:06:53Z","timestamp":1726931213000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/120\/11\/1241\/7716874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":177,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,7,19]]},"published-print":{"date-parts":[[2024,9,21]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvae142","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,7]]}}}